In a 26-week henagliflozin trial, 90% of patients taking henagliflozin gained telomere length compared to 66% of patients receiving placebo
Agree
Disagree
Overview
Debates
Related claims
Topics
B
b5a31f81
Topic
Clinical trials
232
claims
·
240
news stories
0
Opening sign-in…